Virtus Fund Advisers, LLC Amphastar Pharmaceuticals, Inc. Transaction History
Virtus Fund Advisers, LLC
- $25 Million
- Q2 2024
A detailed history of Virtus Fund Advisers, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Virtus Fund Advisers, LLC holds 1,178 shares of AMPH stock, worth $62,905. This represents 0.19% of its overall portfolio holdings.
Number of Shares
1,178
Previous 1,090
8.07%
Holding current value
$62,905
Previous $47,000
-0.0%
% of portfolio
0.19%
Previous 0.17%
Shares
3 transactions
Others Institutions Holding AMPH
# of Institutions
282Shares Held
35.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$317 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$143 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$114 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$104 Million0.19% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$86.6 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.62B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...